Pharmaceuticals, Biotechnology and Life Sciences
ALACHUA, Fla.–(BUSINESS WIRE)–CTD Holdings, Inc. (OTCQB: CTDH), a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease…
DUBLIN–(BUSINESS WIRE)–The “Global Contraceptive Market 2019-2027” report has been added to ResearchAndMarkets.com’s offering. The global contraceptives market is estimated to…
Bayer, Bristol-Myers Squibb Company (NYSE: BMY) and Ono Pharmaceutical Co., Ltd. (“Ono”) announced today the three companies have entered into a clinical collaboration agreement to evaluate the combination of Bayer’s kinase inhibitor Stivarga® (regorafenib) and Bristol-Myers Squibb’s / Ono’s anti-PD-1 immune checkpoint inhibitor, Opdivo® (nivolumab) in patients with micro-satellite stable metastatic colorectal cancer (MSS mCRC), the most common form of mCRC.1
DUBLIN–(BUSINESS WIRE)–The “Phase II/III Study Trends and Market Outlook (2018-2022)” report has been added to ResearchAndMarkets.com’s offering. Keeping up-to-date with…
Quotient Sciences and global investment firm Permira today announced that a company backed by the Permira Funds has signed a definitive agreement to acquire a majority stake in Quotient from companies controlled by GHO Capital and other investors for an undisclosed sum.
Key data now being collected to support endpoint assessment for future gene therapy clinical trial NEW YORK–(BUSINESS WIRE)–Neurogene Inc., a…
Nexien BioPharma was granted patent for “Use of Cannabinoids and Terpenes for Treatment of Organophosphate and Carbamate Toxicity” by the Israeli Patent Office.
DUBLIN–(BUSINESS WIRE)–The “United States Microcarrier Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2024” report has been added…
Patient-reported data will help inform research in rare form of eye cancer OXFORD, England & CONSHOHOCKEN, Pa. & ROCKVILLE, Md.…
ST. HELIER, Jersey–(BUSINESS WIRE)–#btsm–Novocure (NASDAQ: NVCR) today announced the Medicare durable medical equipment (DME) Medicare Administrative Contractors (MACs) have released…